chronic obstructive pulmonary disease
Conditions
Interventions
experimental group:COPD educational booklet face-to-face counselling sessions of experts to patients
Control Group:usual care
Sponsors
State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases,First Affiliated Hospital, Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
40 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Chinese male or female outpatients aged 40 to 85 years; 2. Patients with an new established diagnosis of COPD, defined as 2011 GOLD guideline: Postbronchodilation FEV1/FVC ratio of <70%; 3. patients in stable stages,defined as having no respiratory infections within 4 weeks; 4. Patients who must be able to converse in and read. Patients who must also understand the study and give informed consent; 5. Patients willing and able to complete relevant examinations.
Exclusion criteria
Exclusion criteria: 1. history of an lung function diagnosed COPD or emphysema or cor pulmonale; 2. in addition to COPD, having an other major diseases, defined as: diseases or condition that would make the patients at risk when participating in the reseach, or would affect the reseach results, or would limit patients ability with fininshing the reseach according to the researcher's judgment; 3. clinical diagnosis of lung cancer, bronchiectasis, pneumoconiosis, or other simple restrictive ventilatory dysfunction; 4. serious heart, brain, liver, kidney and blood system diseases or malignant tumor, etc. 5. history of asthma and/or allergic rhinitis; 6. active tuberculosis; 7. a life-threatening pulmonary embolism, or alpha 1 - antitrypsin deficiency, or cystic fibrosis; 8. history of pneumonectomy; 9. COPD exacerbations within 4 weeks before the first visit (V0), or need to be hospitalized and/or antibiotic treatment and/or oral or intravenous hormone therapy during recruiting time (could be delay); 10. cognitive impairment and mental disorder; 11. musculoskeletal or nervous system disorders as cannot undertake everyday activities; 12. history of retinal detachment; 13. history of chronic alcoholism, drug abuse, or any other factors that affect adherence; 14. currently engaged in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| number and severity of COPD exacerbation; | — |
Secondary
| Measure | Time frame |
|---|---|
| last days and treatment of COPD exacerbation;self-management efficacy;medication accuracy and compliance;post-broncholidator FEV1?FVC?FEV1/FVC;distance of 6MWT;MMRC;CAT;CCQ;PE; | — |
Countries
China
Contacts
Public ContactRan Peixin
Outcome results
None listed